San Francisco, CA, United States of America

E David Leonardo


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1999-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: E David Leonardo: Innovator in Netrin Receptors

Introduction

E David Leonardo is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly through his work on netrin receptors. With a total of 4 patents, his innovations have the potential to impact various therapeutic applications.

Latest Patents

One of his latest patents focuses on vertebrate UNC-5 proteins, which serve as receptor proteins for netrins, a family of cell guidance proteins. This invention outlines methods and compositions that allow for the recombinant production of these proteins from transformed host cells. Additionally, it includes the purification of these proteins from human cells. The patent also provides specific hybridization probes and primers that can hybridize with the vertebrate unc-5 gene. Furthermore, it details the development of UNC-5-specific binding agents, such as antibodies, and methods for utilizing these compositions in diagnosis and therapy within the biopharmaceutical industry.

Career Highlights

E David Leonardo is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its innovative approach to understanding cell guidance mechanisms.

Collaborations

Some of his notable coworkers include Lindsay Hinck and Masayuki Masu, who contribute to the collaborative research efforts in his projects.

Conclusion

E David Leonardo's contributions to the field of biopharmaceuticals through his patents on netrin receptors highlight his role as an influential inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…